Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Open Access
- 1 October 1985
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 162 (4) , 1304-1318
- https://doi.org/10.1084/jem.162.4.1304
Abstract
Three herpes simplex virus type I (HSV-I) glycoproteins of apparent molecular masses 103, 63, and 115 kD have been purified using virus-specific monoclonal antibodies (mAb) G8D1, C2D2, and T157, respectively. Both G8D1 and C2D2 neutralize HSV-I in vitro and passively protect CBA mice against HSV-I infection in vivo, whereas T157 is neither neutralizing nor passively protective. However, mice given a single subcutaneous injection of 30 .mu.g 115 kD glycoprotein in saline were completely protected against lethal challenges of HSV-I administered intraperitoneally or in the footpad 7 d after immunization. In contrast, mice similarly immunized with 103 or 63 kD glycoproteins were only partially protected. The prophylactic immunity was correlated with an early induction of specific antibody, which became even more evident 3 d after virus challenge. There was a remarkable similarity in antibody isotype distribution bteween the responses to 115 kD glycoprotein and to heat-inactivated intact HSV-1. However, the prechallenge sera from 115 kD glycoprotein hyperimmunized mice were again neither virus-neutralizing nor passively protective. All three glycoproteins induced only low levels of delayed-type hypersensitivity (DTH). Pretreatment of mice with cyclophosphamide significantly enhanced DTH to 115 kD and 103 kD glycoproteins in the absence of antibody, but failed to confer significant immunity, indicating that DTH alone is insufficient for protection. Splenic and lymph node Ig- (B cell-depleted) cells from mice protectively immunized with 115 kD glycoprotein could adoptively transfer effective protection and enhance a virus neutralizing antibody response in normal recipients challenged with a lethal dose of HSV-1. Both the protection and the ability to enhance neutralizing antibody were diminished when the cells were treated with mAb GK 1.5 and complement. These results therefore demonstrate that the 115 kD glycoprotein, though not apparently containing accessible epitopes for the induction of virus-neutralizing antibody, possesses determinants capable of activating helper T cells. These L3T4+ cells confer strong protective immunity by enhancing protective antibody upon challenge infection, probably through associative help.This publication has 43 references indexed in Scilit:
- The characterization and purification of DNA binding proteins present within herpes simplex virus infected cells using monoclonal antibodiesArchiv für die gesamte Virusforschung, 1984
- Self‐ and allo‐specific suppressor T cells evoked by intravenous injection of F proteinEuropean Journal of Immunology, 1984
- Monoclonal antibodies to herpes simplex virus type 1 glycoproteins show that epitope location influences virus neutralizationJournal of Medical Virology, 1984
- The covalent coupling of proteins to periodate-oxidized sephadex: A new approach to immunoadsorbent preparationJournal of Immunological Methods, 1976
- Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.1975
- A Film Detection Method for Tritium‐Labelled Proteins and Nucleic Acids in Polyacrylamide GelsEuropean Journal of Biochemistry, 1974
- Type-specific protein in herpes simplex virus envelope reacts with neutralising antibodyNature, 1974
- Immune mechanisms by which the spread of viral infections is stoppedCellular Immunology, 1974
- Delayed Hypersensitivity to Herpes Simplex Virus in the Guinea PigThe Journal of Immunology, 1966
- A herpes simplex skin test diagnostic antigen of low protein content from cell culture fluid.1961